Informa (INF) H2 2018 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2018 earnings summary
23 Oct, 2026Executive summary
2018 centered on combining with UBM, with the combination effective June 16; underlying revenue growth was 3.7%, accelerating from 3.4% in 2017.
Integration advanced across brands, leadership, sales, pricing and scheduling; back-end systems integration is expected to continue through 2019 and 2020.
The strategy prioritizes specialist, market-focused businesses, international reach and recurring or forward-booked revenue.
Financial highlights
Reported revenue rose almost 35% to £2.4bn; adjusted operating profit increased 34% to £732m.
Adjusted diluted EPS increased 7% to 49.2p; free cash flow rose 25.5% to £503m.
Revenue growth bridge included 3.7% underlying growth, a 35% contribution from UBM, a 3.8% FX headwind and a 0.4% biennial-phasing impact.
Interest expense was £82m; the effective tax rate fell to just under 18%, primarily due to U.S. tax-law changes.
Outlook and guidance
2019 ambition is for full-year underlying revenue growth above 3.5%; pro forma 2018 growth was ~3.4%.
2019 synergy benefit is targeted at £50m, with run-rate savings of £60m by end-2020 and £75m by end-2021.
2019 operating margin expectations were 31%–32%, reflecting synergies and the lower-margin full-year UBM contribution; longer-term margin guidance was not specified.
Over 65% of revenue comes from forward-booked exhibition contracts, subscriptions and sponsorship contracts; 2019 effective tax-rate expectation is 19%.
Fashion investment aims to address operational issues and restore growth; benefits are expected to become visible from 2020.
Latest events from Informa
- Global pharma events pair supply-chain reach with data-led growth opportunities.INF
Investor presentation - 9M revenue grew 6.5%; double-digit adjusted EPS growth guidance was reaffirmed.INF
Q3 2026 TU - Resilient subscriptions and cost actions anchor a £1.7bn FY21 transition-year baseline.INF
H2 2020 - Strong 2019 cash generation met COVID-19 disruption with ~£450m of events rescheduled.INF
H2 2019 - Revenue, cash and earnings grew as exhibitions and U.S. scale reshaped the portfolio.INF
H2 2016 - Strong cash generation and rising dividends funded a measured growth and portfolio reset.INF
H2 2014 - Record 26.4% operating margin, strong cash generation and lower debt marked FY2011.INF
H2 2011 - Revenue rose 30.7%, underlying growth accelerated, and 2018 growth target topped 3.5%.INF
H2 2017 - 10.1% five-month growth, a £0.5bn buyback and a Q4 2024 TechTarget target.INF
AGM 2024 & Trading update